Open AccessEffect of Ect2 Expression on the Growth of Triple-Negative Breast Cancer Cells with Paclitaxel Intervention
Author(s) -
Hongkun Wang,
Honggang Liu,
Jun Li,
Shuanyu Wei,
Xiaojun Liu,
Huili Wan,
Peiming Zheng,
Huixia Zheng
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s275725
Subject(s) - paclitaxel , apoptosis , triple negative breast cancer , cell growth , cancer research , cell cycle , immunohistochemistry , medicine , cancer , breast cancer , cell , chemistry , oncology , biochemistry
To identify the expression levels of ECT2 (epithelial cell transforming sequence 2) in triple-negative breast cancer (TNBC) before and after administration of paclitaxel (PTX) and explore the interaction between ECT2 and PTX in breast cancer treatment.